GlassScriptPhysician profile
Alison Michele Launhardt
NPI 1891105987
$6,440.02
in general payments reported to CMS, 2019-2025
34 companies · $1,573 in 2025
The $1,573 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $383 · 2020: $305 · 2021: $371 · 2022: $1,079 · 2023: $1,187 · 2024: $1,543 · 2025: $1,573.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,017 · Education: $285.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,016.68 |
| Education | $285.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $876.39 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $837.15 | 2023-2025 | |
| Janssen Biotech, INC. | $510.37 | 2022-2025 | Tremfya |
| Incyte Corporation | $402.96 | 2021-2025 | Opzelura |
| Regeneron Healthcare Solutions, INC. | $397.55 | 2019-2025 | Dupixent |
| Amgen INC. | $380.53 | 2019-2025 | Otezla, Otezla |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $358.63 | 2021-2025 | Cabtreo, Jublia, Siliq |
| Ucb, INC. | $332.44 | 2022-2025 | Bimzelx |
| Pfizer INC. | $320.41 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $234.88 | 2021-2025 | Absorica Ld, Winlevi |
| E.R. Squibb & Sons, L.L.C. | $209.54 | 2022-2025 | Sotyktu |
| Dermavant Sciences, INC. | $187.62 | 2023-2024 | Vtama |
| Lilly USA, LLC | $185.05 | 2019-2023 | Olumiant, Taltz |
| Galderma Laboratories, L.P. | $177.80 | 2019-2025 | Nemluvio, Aklief, Oracea |
| Genzyme Corporation | $153.05 | 2019-2025 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almirall LLC | $146.17 | 2019-2022 | |
| Leo Pharma INC. | $91.84 | 2022-2025 | Adbry, Anzupgo |
| Biofrontera INC. | $80.76 | 2022-2023 | Ameluz, Xepi, Bf-Rhodoled |
| Chiesi USA, INC. | $68.22 | 2025 | Filsuvez |
| Genentech USA, INC. | $67.16 | 2019-2020 | |
| Arcutis Biotherapeutics, INC. | $46.83 | 2024-2025 | Zoryve |
| Kerecis Limited | $45.49 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Mayne Pharma Commercial LLC | $42.64 | 2019-2025 | |
| Epi Health, LLC | $42.61 | 2022 | |
| Organon LLC | $42.38 | 2025 | Vtama |
| Paratek Pharmaceuticals, INC. | $35.73 | 2022 | |
| Botanix Sb INC | $31.92 | 2025 | Sofdra |
| Aclaris Therapeutics, INC. | $28.89 | 2019 | |
| Encore Dermatology INC. | $26.01 | 2020 | |
| Journey Medical Corporation | $18.44 | 2020 | |
| Celgene Corporation | $16.69 | 2019 | |
| Vyne Pharmaceuticals INC. | $15.93 | 2020 | |
| Lnhc, INC | $14.07 | 2025 | Zelsuvmi |
| Krystal Biotech INC | $13.87 | 2025 | Vyjuvek |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alison Launhardt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.